Adebamowo, ClementBah-Sow, OumouBinka, FredBruzzone, RobertoCaplan, ArthurDelfraissy, Jean-FrançoisHeymann, DavidHorby, PeterKaleebu, PontianoMuyembe, Jean-JacquesOlliaro, PieroPiot, PeterTejan-Cole, AbdulTomori, OyewaleToure, AissatouTorreele, ElseWhitehead, John2022-01-032022-01-032014Adebamowo, C., Bah-Sow, O., Binka, F., Bruzzone, R., Caplan, A., Delfraissy, J. F., ... & Whitehead, J. (2014). Randomised controlled trials for Ebola: practical and ethical issues. The Lancet, 384(9952), 1423-1424.https://doi.org/10.1016/S0140-6736(14)61734-7https://nru.uncst.go.ug/xmlui/handle/123456789/9842 months ago, when the numbers known to have died from Ebola in west Africa could still be counted in hundreds, WHO made an important statement about investigational drugs and vaccines. This crisis is so acute, WHO declared, that it is ethical to off er interventions with potential benefi ts but unknown effi cacy and side-eff ects, though every eff ort should be made to evaluate benefi ts and risks and share all data generated.enEbolaEthical IssuesArticle